This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04313/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04313/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/drug/DB04313/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n5http://linked.opendata.cz/resource/drugbank/drug/DB04313/identifier/pdb/

Statements

Subject Item
n2:DB04313
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n8:DB04313 n13:DB04313
dcterms:title
3-Methyl-Aspartic Acid
adms:identifier
n4:DB04313 n5:ACB n9:5287600 n10:46507756
n6:synonym
ACB 2AS Beta-Methyl-Aspartic Acid D-methyl aspartic acid
n6:IUPAC-Name
n11:271B4E85-363D-11E5-9242-09173F13E4C5
n6:InChI
n11:271B4E8B-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n11:271B4E8A-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n11:271B4E87-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n11:271B4E88-363D-11E5-9242-09173F13E4C5
n6:SMILES
n11:271B4E89-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n11:271B4E83-363D-11E5-9242-09173F13E4C5
n6:logP
n11:271B4E81-363D-11E5-9242-09173F13E4C5 n11:271B4E84-363D-11E5-9242-09173F13E4C5
n6:logS
n11:271B4E82-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n11:271B4E91-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n11:271B4E92-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n11:271B4E8C-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n11:271B4E8D-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n11:271B4E8F-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n11:271B4E8E-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n11:271B4E90-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n11:271B4E97-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n11:271B4E99-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n11:271B4E9A-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n11:271B4E96-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n11:271B4E95-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n11:271B4E98-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n11:271B4E86-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n11:271B4E93-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n11:271B4E94-363D-11E5-9242-09173F13E4C5